SULJE VALIKKO

avaa valikko

Artificial Intelligence for Drug Product Lifecycle Applications
162,90 €
Elsevier Science & Technology
Sivumäärä: 298 sivua
Asu: Pehmeäkantinen kirja
Julkaisuvuosi: 2024, 09.09.2024 (lisätietoa)
Kieli: Englanti
Artificial Intelligence for Drug Product Lifecycle Applications explains the use of artificial intelligence (AI) in drug discovery and development paths, including the clinical and postapproval phases. This book gives methods for each of the drug development steps, from the fundamentals to postapproval drug product. AI is a synergistic assembly of enhanced optimization strategies with particular applications in pharmaceutical development and advanced tools for promoting cost-effectiveness throughout the drug lifecycle. Specifically, AI brings together the potential to improve drug approval rates, reduce development costs, get medications to patients faster, and help patients comply with their treatments.

Accelerated pharmaceutical development and drug product approval rates will enable larger profits from patent-protected market exclusivity. This book offers the tools and knowledge to create the right AI strategy to extend the landscape of AI applications across the drug lifecycle. It is especially useful for pharmaceutical scientists, health care professionals, and regulatory scientists, as well as advanced students and postgraduates actively involved in pharmaceutical product and process development involving the use of artificial intelligence in drug delivery applications.

Loppuunmyyty
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Artificial Intelligence for Drug Product Lifecycle Applicationszoom
Näytä kaikki tuotetiedot
ISBN:
9780323918190
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste